Charles River Laboratories International Inc (CRL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Charles River Laboratories International Inc (CRL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7159
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The organization also offers clinical, manufacturing and operations and staffing support. It focuses on providing solutions targeted against therapeutic areas of cardiovascular, central nervous system, metabolic inflammation, oncology, ophthalmology, respiratory disease and musculoskeletal disease. Charles River caters its products and services to pharmaceutical and biotechnology companies, government agencies, as well as leading hospitals and academic institutions. It operates through its network facilities located worldwide. Charles River is headquartered in Wilmington, Massachusetts, the US.

Charles River Laboratories International Inc (CRL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Charles River Laboratories International Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Charles River Laboratories International Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Charles River Laboratories International Inc, Medical Equipment, Deal Details 12
Partnerships 12
Charles River Lab Enters into Licensing Agreement with ERS Genomics 12
InSphero to Enter into Licensing Agreement with Charles River Labs 13
SenzaGen Enters into Distribution Agreement with Charles River Laboratories 14
Charles River Labs Expands Agreement with OcellO 15
Charles River and PathoQuest Expand Biologics Partnership 16
Molecular Imaging Enters into Co-Promotion Agreement with Oncotest 17
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson’s Disease 18
Charles River Labs Enters Into Agreement With Bruker For Axcess System 19
Reinnervate Enters Into Co-Marketing Agreement With Oncotest For Alvetex Scaffold Technology 20
Equity Offering 21
Charles River Laboratories International Plans to Raise Funds in Public Offering of Securities 21
Debt Offering 22
Charles River Lab Raises USD500 Million in Private Placement of 5.5% Senior Notes Due 2026 22
Asset Transactions 23
AAIPharma Services Acquires Celsis Analytical Services From Celsis International 23
Acquisition 24
Charles River Laboratories Acquires MPI Research for USD800 Million 24
Charles River Labs Acquires Celsis International for USD214.5 Million 26
MPI Research Acquired Jasper Clinic, Clinical Research Organization 27
Charles River Labs Acquires Accugenix, Provider Of Microbe Identification Services, For USD18.4 Million 28
Charles River Laboratories International Inc – Key Competitors 29
Charles River Laboratories International Inc – Key Employees 30
Charles River Laboratories International Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 36
Strategy And Business Planning 36
Jun 19, 2018: Charles River Laboratories Joins UConn TIP 36
Financial Announcements 37
Aug 08, 2018: Charles River Laboratories announces second-quarter 2018 results from continuing operations 37
May 10, 2018: Charles River Laboratories Announces First-Quarter 2018 Results from Continuing Operations 39
Feb 13, 2018: Charles River Laboratories Announces Fourth-Quarter 2017 Financial Results 41
Nov 09, 2017: Charles River Laboratories Announces Third-Quarter 2017 Results from Continuing Operations 44
Aug 09, 2017: Charles River Laboratories Announces Second-Quarter 2017 Results from Continuing Operations 46
May 10, 2017: Charles River Laboratories Announces First-Quarter 2017 Results from Continuing Operations 48
Feb 14, 2017: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2016 Results from Continuing Operations and Provides 2017 Guidance 50
Corporate Communications 53
Feb 13, 2018: Charles River Laboratories Announces Executive Management Appointments 53
Jan 16, 2018: Charles River Laboratories Adds Jean-Paul Mangeolle to Board of Directors 54
Jul 05, 2017: Charles River Laboratories Adds Martin Mackay, Ph.D. to Board of Directors 55
Product News 56
Nov 01, 2017: Charles River Laboratories Presents Newly Expanded Capabilities at Neuroscience 2017 56
Other Significant Developments 58
Mar 08, 2018: Charles River Laboratories Makes Expansions to Global Biologics Infrastructure 58
Dec 06, 2017: Charles River Adds ERS License to CRISPR/Cas9 Service Offering 59
Jun 28, 2017: SenzaGen signs global distribution agreement with Charles River Laboratories 60
May 16, 2017: Charles River Laboratories Announces Updates to Oncology Business 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
Charles River Laboratories International Inc, Medical Equipment, Key Facts, 2017 2
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Charles River Laboratories International Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Charles River Laboratories International Inc, Deals By Market, 2012 to YTD 2018 9
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Charles River Lab Enters into Licensing Agreement with ERS Genomics 12
InSphero to Enter into Licensing Agreement with Charles River Labs 13
SenzaGen Enters into Distribution Agreement with Charles River Laboratories 14
Charles River Labs Expands Agreement with OcellO 15
Charles River and PathoQuest Expand Biologics Partnership 16
Molecular Imaging Enters into Co-Promotion Agreement with Oncotest 17
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson's Disease 18
Charles River Labs Enters Into Agreement With Bruker For Axcess System 19
Reinnervate Enters Into Co-Marketing Agreement With Oncotest For Alvetex Scaffold Technology 20
Charles River Laboratories International Plans to Raise Funds in Public Offering of Securities 21
Charles River Lab Raises USD500 Million in Private Placement of 5.5% Senior Notes Due 2026 22
AAIPharma Services Acquires Celsis Analytical Services From Celsis International 23
Charles River Laboratories Acquires MPI Research for USD800 Million 24
Charles River Labs Acquires Celsis International for USD214.5 Million 26
MPI Research Acquired Jasper Clinic, Clinical Research Organization 27
Charles River Labs Acquires Accugenix, Provider Of Microbe Identification Services, For USD18.4 Million 28
Charles River Laboratories International Inc, Key Competitors 29
Charles River Laboratories International Inc, Key Employees 30
Charles River Laboratories International Inc, Subsidiaries 32

List of Figures
Charles River Laboratories International Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Charles River Laboratories International Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Charles River Laboratories International Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Charles River Laboratories International Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Charles River Laboratories International Inc (CRL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sysmex America Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sysmex America Inc (Sysmex America), a subsidiary of Sysmex Corp is a medical device company that manufactures laboratory testing equipments. The company's products include clinical diagnostic devices, in vitro diagnostic hematology devices, urinalysis devices, reagents and information syste …
  • Gartner Inc (IT):企業の財務・戦略的SWOT分析
    Gartner Inc (IT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Navidea Biopharmaceuticals Inc (NAVB)-医療機器分野:企業M&A・提携分析
    Summary Navidea Biopharmaceuticals Inc (Navidea) is a precision medicine company that focuses on the development and commercialization of radiopharmaceutical agents and precision diagnostics. Its key product, Lymphoseek (technetium Tc 99m tilmanocept) injection, is a radiopharmaceutical agent used i …
  • Luitpold Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Luitpold Pharmaceuticals Inc (Luitpold), a subsidiary of Daiichi Sankyo Company Ltd is a manufacturer and marketer of drugs and medical devices. The company provides injectable parenteral medications that are used in pharmacy admixtures and nutrient solutions, antidotes, critical care drugs, …
  • St. Augustine Gold and Copper Limited:企業の戦略・SWOT・財務情報
    St. Augustine Gold and Copper Limited - Strategy, SWOT and Corporate Finance Report Summary St. Augustine Gold and Copper Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Bactiguard Holding AB (BACTI B):医療機器:M&Aディール及び事業提携情報
    Summary Bactiguard Holding AB (Bactiguard) is a medical device manufacturer which develops and supplies infection protection solutions and antibiotics. The company’s product portfolio includes urinary catheters, foley catheters (BIP Foley catheters), endotracheal tubes and central venous catheters. …
  • Innergex Renewable Energy Inc (INE):電力:M&Aディール及び事業提携情報
    Summary Innergex Renewable Energy Inc (Innergex) is an independent renewable power producer. It develops, acquires, owns and operates hydroelectric facilities, wind farms, and solar photovoltaic geothermal power facilities. Through long-term power purchase agreements, the company sells electricity t …
  • Australian Mines Limited:企業の戦略・SWOT・財務分析
    Australian Mines Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Mines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • U.S. HealthWorks Medical Group-製薬・医療分野:企業M&A・提携分析
    Summary U.S. HealthWorks Medical Group (U.S. HealthWorks), a subsidiary of Dignity Health is a healthcare service provider that offers physical therapy, rehabilitation and medical review. The center’s services include occupational medicine, urgent care, specialty care and therapy services. Its occup …
  • Interpace Biosciences Inc (IDXG):企業の製品パイプライン分析
    Summary Interpace Biosciences Inc (Interpace Biosciences) formerly Interpace Diagnostics Group Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathf …
  • Tong Yang Life Insurance Co., Ltd.
    Tong Yang Life Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tong Yang Life Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • CohBar Inc (CWBR):製薬・医療:M&Aディール及び事業提携情報
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • Emerald Bay Energy Inc (EBY):石油・ガス:M&Aディール及び事業提携情報
    Summary Emerald Bay Energy Inc (Emerald Bay) is an oil and gas exploration and production company that acquires, explores and develops petroleum and natural gas properties in Western Canada and South Texas. The company's energy portfolio includes natural gas, oil, and electrical power generation. It …
  • West Fraser Timber Co. Ltd. (WFT):企業の財務・戦略的SWOT分析
    West Fraser Timber Co. Ltd. (WFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • GLG Life Tech Corp (GLG):企業の財務・戦略的SWOT分析
    GLG Life Tech Corp (GLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • KPJ Healthcare Berhad (KPJ):企業の財務・戦略的SWOT分析
    Summary KPJ Healthcare Berhad (KPJ) is a healthcare service provider that offers medical services. The center offers services in the areas of anaesthesiology, cardiology and cardiothoracic surgery, child psychiatry, clinic pathology, occupational health services, orthopaedic and trauma surgery, diet …
  • Vail Resorts Inc:戦略・SWOT・企業財務分析
    Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Vale Canada Ltd:企業の戦略・SWOT・財務分析
    Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report Summary Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Daito Trust Construction Co., Ltd.
    Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Sirona Biochem Corp (SBM):企業の財務・戦略的SWOT分析
    Summary Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It provides cosmeceutical programs such as development of anti-aging and depigmenting agent …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆